| dc.contributor.author | Manna, S K | |
| dc.contributor.author | Singh, Priyanka | |
| dc.contributor.author | Mondal, Sankalan | |
| dc.contributor.author | Goyal, Manish | |
| dc.contributor.author | Bandyopadhyay, Uday | |
| dc.contributor.author | Panda, Gautam | |
| dc.date.accessioned | 2017-05-31T08:01:57Z | |
| dc.date.available | 2017-05-31T08:01:57Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | SOP Transactions on Organic Chemistry, 2014, 1(2), 8-20 | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/1695 | |
| dc.description.abstract | Focused libraries of Trisubstituted methanes (TRSMs) have been synthesized through Grignard reaction of aryl magnesium bromide with various carbaldehydes followed by Friedel-Crafts alkylation of diaryl carbinols with electron rich aryl and heteroaryl thiols. These compounds were investigated to inhibit parasite growth and development and displayed strong anti-malarial activity in vitro against human malaria parasite Plasmodium falciparum. The synthesized TRSMs interact well with free heme and form stable TRSM-heme complexes. Furthermore, they also inhibit β-hematin formation (hemozoin formation) in a concentration dependent manner. Measurement of heme binding affinity and hemozoin inhibition for TRSMs revealed strong correlation with anti-malarial potency. Structure activity relationship revealed that TRSMs containing pyridyl and quinoline ring were more efficient to offer anti-malarial activity. | en |
| dc.format.extent | 317477 bytes | |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | CSIR-CDRI communication no. 8775 | en |
| dc.subject | Trisubstituted methanes | en |
| dc.subject | Anti-malarial agent | en |
| dc.subject | Structure-activity relationship | en |
| dc.title | Trisubstituted Methanes (TRSMs): Synthesis and Bioevaluation as Anti-malarials | en |
| dc.type | Article | en |